Central India Cardiology and Research Institute

Nagpur 440015

1 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Disease, Chronic Migraine, Episodic Migraine, Obesity, Overweight, Overweight or Obesity, Peripheral Arterial Disease, Type 2 Diabetes

Studies at this site

• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine — Running, not enrolling
• A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine — Running, not enrolling